Sanofi Regeneron $1B

Sanofi to pay Regeneron $1 billion upfront in expanded immunology deal

Sanofi will pay Regeneron $1 billion upfront plus up to $7 billion in milestones to expand their immunology antibody partnership, including Dupixent. The deal settles litigation, splitting costs and p